Staar Surgical (Nasdaq:STAA) announced today that it appointed Warren Foust as its new president and CEO. The appointment went into effect today, Aug. 4, 2026. Alongside Foust’s appointment, Lake Forest, California-based Staar named Deborah Andrews, its CFO, an EVP as well. Foust and Andrews became interim co-CEOs in February, following the resignation of CEO Stephen […]
STAAR Surgical Co
FDA expands age indication for Staar Surgical EVO ICL
Staar Surgical (Nasdaq:STAA) announced that it received FDA approval for an expanded age indication for its Evo lenses. Evo Visian Implantable Collamer Lenses (ICL) can now extend to patients between the ages of 21 and 60 years old. Its previous indication covered patients between 21 and 45. The expanded approval comes on the heels of […]
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal
Staar Surgical (Nasdaq:STAA) announced today that it appointed Warren Foust and Deborah Andrews as interim co-CEOs. The temporary appointments of both executives, who currently hold other leadership roles at Staar, went into effect yesterday, Feb. 1. They follow a topsy-turvy period for the company, which is undergoing a leadership change after a failed merger with […]
Staar Surgical to terminate Alcon deal after stockholder vote
Staar Surgical (Nasdaq:STAA) announced today that preliminary estimates suggest that it failed to receive stockholder approval for its planned merger with Alcon . The company’s proxy solicitor delivered the preliminary estimates, throwing yet another wrench into the maligned attempted merger — one of the biggest deals put on the table in 2025. As a result […]
Alcon amends Staar merger agreement as deal looks set to move forward
Alcon announced today that it entered into an amended merger agreement for its planned acquisition of Staar Surgical (Nasdaq:STAA). The companies amended their agreement after the “go-shop” period for the deal, which allowed other potential bidders to come in for Staar, expired on Dec. 6. Following that expiration and the amendment to the deal, the […]
Alcon’s Staar Surgical acquisition clears hurdle as ‘window shop’ period closes
Staar Surgical (Nasdaq:STAA) announced today that the 45-day “window shop” period for its merger with Alcon expired. This period expired at the end of the day on Friday, Sept. 19. The company saw no competing acquisition proposal, despite efforts to find a new buyer from Staar’s largest shareholder. In August, Alcon announced that it agreed to […]
Staar Surgical’s board urges stockholders to approve Alcon acquisition in face of scrutiny
Staar Surgical (Nasdaq:STAA) announced today that it filed a definitive proxy statement related to its planned merger with Alcon . In conjunction with the proxy statement, the company issued a letter to its stockholders outlining its desire to move forward with the deal. In August, Alcon announced that it agreed to acquire Staar in a deal […]
Alcon faces opposition from Staar Surgical’s largest shareholder in planned acquisition
Broadwood Partners said today that it intends to vote against the proposed acquisition of Staar Surgical (Nasdaq:STAA) by Alcon . In August, Alcon announced that it agreed to acquire Staar in a deal with an equity value of approximately $1.5 billion. With the acquisition, Alcon would bring in the Staar family of Evo Implantable Collamer […]
Alcon to acquire Staar Surgical in $1.5B deal
Alcon announced today that it entered into a definitive merger agreement through which it acquires Staar Surgical (Nasdaq:STAA). Under the terms of the agreement, Alcon intends to purchase all outstanding shares of Staar common stock for $28 apiece in cash. That represents approximately a 59% premium on Staar’s 90-day volume-weighted average price and a 51% […]
Staar Surgical shakes up leadership structure
Staar Surgical (Nasdaq:STAA) announced that it made a series of changes to realign its leadership structure to better address market needs. The shift atop the company comes around a month after the company laid off more than 100 workers amid challenging market conditions. Lake Forest, California–based Staar, a maker of Implantable Collamer lenses, created a […]
Staar Surgical rises on Street-beating Q2, raised guidance
Staar Surgical (NSDQ:STAA) shares ticked up today on second-quarter results that topped the consensus forecast. The Lake Forest, Calif.-based implantable lens maker posted profits of $8.6 million, or 17¢ per share, on sales of $62.4 million for the three months ended July 2, 2021, for a massive bottom-line from over $1 million in the red […]
